RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis

Chenggang Li, Zhiming Zhao, Zhipeng Zhou, Rong Liu

Open source

DOI
10.1007/s00280-016-3178-4
Published
2016-10-26
Container
Cancer Chemotherapy and Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-016-3178-4,
  title = {RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis},
  author = {Chenggang Li and Zhiming Zhao and Zhipeng Zhou and Rong Liu},
  year = {2016},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-016-3178-4},
  url = {https://doi.org/10.1007/s00280-016-3178-4}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
AU  - Chenggang Li
AU  - Zhiming Zhao
AU  - Zhipeng Zhou
AU  - Rong Liu
PY  - 2016
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-016-3178-4
UR  - https://doi.org/10.1007/s00280-016-3178-4
ER  - 

APA

Li, C., Zhao, Z., Zhou, Z., & Liu, R. (2016). RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-016-3178-4

Source records